Rationale and Design for PACE: Patients with Intermittent Claudication Injected with ALDH Bright Cells

Peripheral artery disease (PAD) is recognized as a public health issue because of its prevalence, functional limitations, and increased risk of systemic ischemic events. Current treatments for claudication, the primary symptom in PAD patients, have limitations. Cells identified usingcytosolic enzyme...

Full description

Saved in:
Bibliographic Details
Published in:Am Heart J
Main Authors: Perin, Emerson C., Murphy, Michael, Cooke, John P., Moyé, Lem, Henry, Timothy D., Bettencourt, Judy, Gahremanpour, Amir, Leeper, Nicholas, Anderson, R. David, Hiatt, William R., Lima, Joao A., Venkatesh, Bharath, Sayre, Shelly L., Vojvodic, Rachel W., Taylor, Doris A., Ebert, Ray F., Hirsch, Alan T.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4254580/
https://ncbi.nlm.nih.gov/pubmed/25440794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2014.07.021
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items